In 2000, the FDA approved the abortion pill Mifeprex, later approving the generic version in 2019. The drug blocks progesterone, a hormone needed for a woman to carry out a pregnancy. Despite this, on April 14, U.S. Court District Judge Matthew Kacsmryk from Texas issued a nationwide injunction to end the sale of it.
Medical professionals remark that the medication is less dangerous than Tylenol, and many studies over the last couple of decades support its safety and efficacy. Unfortunately, Republican officials are continuing to limit the use of safe abortion options, despite the plethora of research backing the approved drug.
Half of the abortions in the United States rely on this medication, and for many women it can be life saving. For now, the U.S. Supreme Court put a hold on Kecsmyrk’s ruling until they are able to review the case. Access to mifepristone is currently not limited, but is dependent on the Supreme Court’s upcoming decision.
